Ozempic) and tirzepatide (e.g.Mounjaro, Zepbound)
For instance, NAD + levels and mitochondrial function have been shown to decline in sarcopenia muscle in one cohort 249 , while another study did not observe a difference in NAD + levels in sarcopenic muscle, and even NR supplementation had no effect on NAD + levels 262
Summary: Jitteriness is not a recognised side effect of Mounjaro (tirzepatide) according to UK regulatory data, though some patients report shakiness due to indirect factors such as low blood sugar or reduced food intake
When combining medications with supplements, a primary concern is always potential interactions
Posted by Amanda Waesch & Adrianna Globokar
I., Gu, Q., Phukhatmuen, P., et al